Funding Opportunity for Early-Stage Innovators in Scotland
5/1/20261 min read
Early-stage innovators based in Scotland have access to a significant opportunity to advance their programs toward ProofOfConcept, with an additional £2.85M fund from the Scottish Government aimed at supporting early development and enabling further investment.
🗓️ Deadline: 8th May
At Pharmidex, we work alongside our partners to generate robust, translational data that supports confident decision-making across early discovery and preclinical development.
Our capabilities include:
TargetExpression
ModeOfActionStudies
TargetEngagement
HitIdentification
ADME and PK profiling
If you are preparing an application and require scientific input or timely quotations, we would be pleased to support your programme.
Contact Us
Address
167-169 Great Portland Street, Fifth Floor, London, W1W 5PF
Contacts
Email: bd@pharmidex.com
